Table 2.
Serum and salivary concentrations of chemerin, α-defensin 1 and TNF- α (ng/mL) in CRC patients and control group.
| Marker Concentration | Control | CRC | p | ||||
|---|---|---|---|---|---|---|---|
| Median | Q1 | Q3 | Median | Q1 | Q3 | ||
| Serum chemerin (ng/mL) | 164.07 | 73.37 | 173.39 | 406.52 | 302.54 | 502.10 | <0.001 |
| Salivary chemerin (ng/mL) | 4.71 | 3.39 | 5.25 | 13.28 | 10.21 | 18.94 | <0.001 |
| Serum α -defensin1 (ng/mL) | 38.51 | 33.58 | 40.95 | 58.83 | 49.47 | 72.84 | <0.001 |
| Salivary α -defensin1 (ng/mL) | 104.39 | 98.23 | 108.95 | 310.92 | 274.09 | 398.84 | <0.001 |
| Serum TNF α (ng/mL) | 7.23 | 6.49 | 7.87 | 207.66 | 176.59 | 302.31 | <0.001 |
| Salivary TNF α (ng/mL) | 4.60 | 3.83 | 5.26 | 141.28 | 115.91 | 176.48 | <0.001 |
Q1, Q3—quartile; p—statistical significance of the Mann–Whitney U test.